Chemkart India shares to debut. GMP hints at flat listing
[hfe_template id='11223']
[ad_1]
Chemkart India is set to debut on the BSE SME platform on Monday, July 14, following the successful closure and allotment of its Rs 80 crore IPO. The IPO, priced at Rs 248 per share, saw solid institutional participation and was fully subscribed across categories. As per market sources, the stock is trading at a modest GMP (grey market premium) of Rs 2, implying a listing upside of just about 1% over the issue price. While muted, this suggests that the listing may remain steady rather than see a dramatic pop. The IPO comprised a fresh issue of Rs 64.48 crore and an offer for sale worth Rs 15.60 crore. Incorporated in 2015, Chemkart India operates as a distributor of food and health ingredients, bridging global suppliers with Indian businesses in the B2B nutrition and supplement space. Its product basket includes amino acids, vitamins, proteins, herbal extracts, sports nutrition ingredients, and nucleotides. These products are widely used ...